{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2022,4,5]],"date-time":"2022-04-05T07:18:36Z","timestamp":1649143116007},"reference-count":10,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[1988,6,1]],"date-time":"1988-06-01T00:00:00Z","timestamp":581126400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[1988,6,1]],"date-time":"1988-06-01T00:00:00Z","timestamp":581126400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Med. Oncol. &amp; Tumor Pharmacother."],"published-print":{"date-parts":[[1988,6]]},"DOI":"10.1007\/bf02985450","type":"journal-article","created":{"date-parts":[[2021,9,17]],"date-time":"2021-09-17T18:21:13Z","timestamp":1631902873000},"page":"125-128","source":"Crossref","is-referenced-by-count":0,"title":["Adriamycin, vincristine and mitomycin C as first and second line therapy for advanced breast carcinoma"],"prefix":"10.1007","volume":"5","author":[{"given":"M.","family":"Harding","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"G.","family":"Sangster","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"R. A. V.","family":"Milsted","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S. B.","family":"Kaye","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"K. C.","family":"Calman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"BF02985450_CR1","doi-asserted-by":"publisher","first-page":"1235","DOI":"10.1002\/1097-0142(19821001)50:7<1235::AID-CNCR2820500703>3.0.CO;2-L","volume":"50","author":"D C Tormey","year":"1982","unstructured":"Tormey D C, Gelman R, Band P Ret al.: Comparison of induction chemotherapies for metastatic breast cancer.Cancer\n                  50, 1235 (1982).","journal-title":"Cancer"},{"key":"BF02985450_CR2","doi-asserted-by":"publisher","first-page":"1553","DOI":"10.1016\/0277-5379(83)90085-8","volume":"19","author":"R Steiner","year":"1983","unstructured":"Steiner R, Stewart J F, Cantwell B M Jet al.: Adriamycin alone or combined with vincristine in the treatment of advanced breast cancer.Eur J Cancer clin Oncol\n                  19, 1553 (1983).","journal-title":"Eur J Cancer clin Oncol"},{"key":"BF02985450_CR3","first-page":"319","volume":"6","author":"D C Tormey","year":"1975","unstructured":"Tormey D C: Adriamycin (NSC \u2014 123127) in breast cancer: an overview of studies.Cancer Chemother Rep\n                  6, 319 (1975).","journal-title":"Cancer Chemother Rep"},{"key":"BF02985450_CR4","doi-asserted-by":"publisher","first-page":"192","DOI":"10.1002\/1097-0142(19830701)52:1<192::AID-CNCR2820520135>3.0.CO;2-W","volume":"52","author":"M A Friedman","year":"1983","unstructured":"Friedman M A, Marcus F S, Cassidy M Jet al.: 5-fluorouracil + oncovin + adriamycin + mitomycin C (FOAM): an effective program for breast cancer, even for disease refractory to previous chemotherapy.Cancer\n                  52, 192 (1983).","journal-title":"Cancer"},{"key":"BF02985450_CR5","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1007\/BF00254262","volume":"11","author":"S K Shipp","year":"1983","unstructured":"Shipp S K, Muss H B, Westrick M Aet al.: Vincristine, doxorubicin and mitomycin (VAM) in patients with advanced breast cancer previously treated with cyclophosphamide, methotrexate and fluorouracil (CMF).Cancer Chemother Pharmac\n                  11, 130 (1983).","journal-title":"Cancer Chemother Pharmac"},{"key":"BF02985450_CR6","doi-asserted-by":"crossref","first-page":"818","DOI":"10.1200\/JCO.1985.3.6.818","volume":"3","author":"K K Jain","year":"1985","unstructured":"Jain K K, Casper E S, Geller N Let al.: A prospective randomised comparison of epirubicin and doxorubicin in patients with advanced breast cancer.J clin Oncol\n                  3, 818 (1985).","journal-title":"J clin Oncol"},{"key":"BF02985450_CR7","first-page":"101","volume":"2","author":"B Hoogstraten","year":"1979","unstructured":"Hoogstraten B, Fabian C: A reappraisal of single drugs in advanced breast cancer.Cancer clin Trials,2, 101 (1979).","journal-title":"Cancer clin Trials"},{"key":"BF02985450_CR8","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1002\/mpo.2950020106","volume":"2","author":"G R Wise","year":"1976","unstructured":"Wise G R, Kuhn I N, Godfrey T E: Mitomycin C in large infrequent doses in breast cancer.Med Ped Oncol\n                  2, 55 (1976).","journal-title":"Med Ped Oncol"},{"key":"BF02985450_CR9","first-page":"448","volume":"22","author":"M W Oster","year":"1981","unstructured":"Oster M W, Park Y, Grossbard L: Vincristine (V), adriamycin (A) and mitomycin (M) therapy for previously treated breast cancer.Proc AACR\/ASCO\n                  22, 448 (1981).","journal-title":"Proc AACR\/ASCO"},{"key":"BF02985450_CR10","doi-asserted-by":"publisher","first-page":"1289","DOI":"10.1002\/1097-0142(197703)39:3<1289::AID-CNCR2820390340>3.0.CO;2-F","volume":"39","author":"J L Hayward","year":"1977","unstructured":"Hayward J L, Carbone P P, Heuson J-Cet al.: Assessment of response to therapy in advanced breast cancer.Cancer\n                  39, 1289 (1977).","journal-title":"Cancer"}],"container-title":["Medical Oncology and Tumor Pharmacotherapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/BF02985450.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/BF02985450\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/BF02985450.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,9,17]],"date-time":"2021-09-17T19:19:54Z","timestamp":1631906394000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/BF02985450"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1988,6]]},"references-count":10,"journal-issue":{"issue":"2","published-print":{"date-parts":[[1988,6]]}},"alternative-id":["BF02985450"],"URL":"https:\/\/doi.org\/10.1007\/bf02985450","relation":{},"ISSN":["0736-0118"],"issn-type":[{"value":"0736-0118","type":"print"}],"subject":[],"published":{"date-parts":[[1988,6]]}}}